Rylan DeStefano

Piqray led to elevated blood sugar in many patients with breast cancer, a recent research showed.

There are many immunotherapy-caused skin toxicities, though most can be easily managed.

As Teddi Mellencamp reveals more about her cancer diagnosis and Shannen Doherty receives a standing ovation after her stage 4 cancer diagnosis, here’s what is happening in the oncology space this week.

Stress, anxiety and depression can affect diet and lifestyle behaviors within young adult cancer survivors.

We asked our audience of patients, survivors and caregivers to those with cancer about their feelings on cancer awareness months. Here's what they had to say.

Women who were previously treated for cancer during childhood with specific chemotherapy have a higher chance of becoming diagnosed with breast cancer.

A new phase 2b/3 trial was approved to study of S-pindolol benzoate to treat cachexia, a wasting disease associated with cancer.

As The Los Angeles Rams celebrate a cancer survivor and a 9/11 survivor reveals his fourth cancer diagnosis, this is what’s happening in the oncology space this week.

The TROPION-Lung04 trial reveals improvements from combining Dato-DXd with Imfinzi with or without carboplatin for patients with previously untreated advanced or metastatic non-small cell lung cancer (NSCLC) without actionable genomic alterations.

The recent FDA approval of Lonsurf plus Avastin for metastatic colorectal cancer improves survival and quality of life, an expert said.

Patients with acute myeloid leukemia who took vitamin C and D supplements experienced fewer complications, but no overall survival benefits.

The phase 3 MARIPOSA- 2 study shows significant improvement within progression free survival after implementing Rybrevant into treatment for patients with non-small cell lung cancer.

As Linda Evangelists announces second cancer diagnosis and a new artificial intelligence tool identifies cancer diagnoses, this is what’s happening in the oncology space this week.

Nutritionist Stephanie Meyers dives into popular misconceptions of food and cancer, and sources that offer reliable information.

As majority leader Steve Scalise announces his new cancer diagnosis and author Ibram X. Kendi reveals that he is cancer free, this is what’s happening in the oncology space this week.

Balversa has been submitted to the FDA for approval to treat patients with locally advanced or metastatic urothelial carcinoma.

The FDA has granted a priority review for the evaluation of Xtandi as a treatment for patients with non-metastatic castration-sensitive prostate cancer.

A phase 3 trial shows that zolbetuximab improved survival in patients with advanced gastric or gastroesophageal junction cancer.

From a former patient with cancer lives her dream of working alongside her doctor, to NASCAR crew chief Tommy Baldwin Jr. announcing his cancer diagnosis, this is what’s going on in the oncology space this week.

Progression-free survival improved with Retevmo as the initial treatment for patients with advanced RET-mutant medullary thyroid cancer.

Chemoimmunotherapy was tested in patients with extensive-stage small cell lung cancer to determine its effect based on different performance statuses.

New PSMA PET/CT can detect signs of prostate cancer within elderly patients without the need of a biopsy.

Adults with cancer can benefit from mindfulness-based interventions and other therapies to manage symptoms of anxiety and depression.

Researchers are using artificial intelligence to diagnose sarcopenia in patients with head and neck cancer.

From Eric Braeden announces that he is cancer free to Tom Jones dying from cancer, this is what’s happening in the oncology space this week.

Social isolation has become prominent among young cancer survivors, though social connectedness may be beneficial to wellbeing, a recent study showed.

There are two different types of lung cancer — small cell and non-small cell lung cancer — that behave differently and therefore require different treatments, an expert explained.

From Jill Martin revealing an updated about her cancer to Casey DeSantis announcing breast cancer diagnosis, this is what’s happening in the oncology space this week.

Researchers have found a new risk biomarker that can detect the early beginnings of graft-versus-host disease in new study.

As wide receiver John Metchie returns to the field after cancer experience, and coach Brent Venables announces wife’s cancer diagnosis, this is what’s happening in the oncology space this week.